Apis Capital Advisors, LLC Novo Cure LTD Transaction History

Apis Capital Advisors, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 13, 2019	SELL	$42.22 - $63.23 $1.07 Million - $1.61 Million	-25,400 Closed	0 $0
Q1 2019 May 07, 2019	SELL	$31.96 - $56.12 $1.78 Million - $3.13 Million	-55,700 Reduced 68.68%	25,400 $1.22 Million
Q4 2018 Feb 14, 2019	BUY	$28.72 - $52.63 $2.33 Million - $4.27 Million	81,100 New	81,100 $2.72 Million

263

76.9M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $2.76B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Apis Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Apis Capital Advisors, LLC with notifications on news.